Catalyst Pharmaceuticals, Inc.
CPRX
$19.89
-$0.7288-3.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 652.80M | 580.66M | 517.55M | 442.33M | 375.69M |
| Total Receivables | 66.31M | 72.26M | 65.49M | 58.27M | 57.28M |
| Inventory | 18.65M | 19.78M | 19.54M | 20.02M | 18.01M |
| Prepaid Expenses | 19.73M | 12.57M | 20.00M | 17.88M | 22.41M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.24M | 452.00K | 1.03M | 509.00K | 1.03M |
| Total Current Assets | 758.74M | 685.72M | 623.61M | 539.00M | 474.43M |
|
|
|||||
| Total Current Assets | 758.74M | 685.72M | 623.61M | 539.00M | 474.43M |
| Net Property, Plant & Equipment | 3.23M | 3.40M | 3.58M | 3.68M | 3.60M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 137.98M | 147.33M | 156.67M | 166.02M | 175.36M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 50.70M | 48.22M | 45.98M | 48.47M | 39.89M |
| Total Assets | 971.92M | 908.87M | 851.41M | 772.01M | 706.36M |
|
|
|||||
| Total Accounts Payable | 5.53M | 11.20M | 16.59M | 11.56M | 7.12M |
| Total Accrued Expenses | 41.76M | 30.95M | 53.85M | 42.66M | 31.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 419.00K | 410.00K | 402.00K | 393.00K | 385.00K |
| Total Finance Division Other Current Liabilities | 65.30M | 69.10M | 49.83M | 50.78M | 53.65M |
| Total Other Current Liabilities | 65.30M | 69.10M | 49.83M | 50.78M | 53.65M |
| Total Current Liabilities | 113.01M | 111.65M | 120.68M | 105.40M | 92.32M |
|
|
|||||
| Total Current Liabilities | 113.01M | 111.65M | 120.68M | 105.40M | 92.32M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.57M | 2.68M | 2.79M | 2.89M | 2.99M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 309.00K | 259.00K | 315.00K | 2.79M | 2.40M |
| Total Liabilities | 115.89M | 114.59M | 123.78M | 111.07M | 97.71M |
|
|
|||||
| Common Stock & APIC | 461.99M | 452.40M | 442.41M | 431.72M | 423.31M |
| Retained Earnings | 394.01M | 341.90M | 285.16M | 229.23M | 185.34M |
| Treasury Stock & Other | 31.00K | -17.00K | 64.00K | -- | -- |
| Total Common Equity | 856.03M | 794.28M | 727.63M | 660.94M | 608.66M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 856.03M | 794.28M | 727.63M | 660.94M | 608.66M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 856.03M | 794.28M | 727.63M | 660.94M | 608.66M |
|
|
|||||